{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:20:23Z","timestamp":1790824823240,"version":"4.1.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.pathol.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T03:31:37Z","timestamp":1462332697000},"page":"303-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Laboratory tests used to help diagnose von Willebrand disease: an update"],"prefix":"10.1016","volume":"48","author":[{"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pasalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-2873","authenticated-orcid":false,"given":"Jennifer","family":"Curnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0031-1280567","article-title":"Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder","volume":"37","author":"Favaloro","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib2","first-page":"17","article-title":"Von Willebrand factor: form for function","volume":"40","author":"Yee","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.71.5.1906","article-title":"Synthesis of von Willebrand factor by cultured human endothelial cells","volume":"71","author":"Jaffe","year":"1974","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.pathol.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1172\/JCI112064","article-title":"Biosynthesis of von Willebrand protein by human megakaryocytes","volume":"76","author":"Sporn","year":"1985","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0049-3848(10)70149-3","article-title":"Rethinking the diagnosis of von Willebrand Disease","author":"Favaloro","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/s-0033-1353442","article-title":"Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect","volume":"39","author":"Othman","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1160\/TH10-08-0523","article-title":"Frequency of Platelet type versus Type 2B von Willebrand disease. An international registry-based study","volume":"105","author":"Hamilton","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0035-1569070","article-title":"Treatment of von Willebrand Disease","volume":"42","author":"Curnow","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1517\/21678707.2015.1066245","article-title":"Recent advances in laboratory-aided diagnosis of von Willebrand disease","volume":"3","author":"Favaloro","year":"2015","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.pathol.2016.03.001_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-2006-947858","article-title":"A\u00a0short history of diagnostic tests for von Willebrand disease: in memory of Barry Firkin (1930 to 2001) and Ted Zimmerman (1937 to 1988)","volume":"32","author":"Koutts","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib12","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0034-1383546","article-title":"Diagnosing von Willebrand disease: a short history of laboratory milestones and innovations, plus current status, challenges, and solutions","volume":"40","author":"Favaloro","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/hae.12710","article-title":"The Platelet Function Analyser (PFA)-100 and von Willebrand disease: a story well over 16 years in the making","volume":"21","author":"Favaloro","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/hae.12653","article-title":"Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year \u2018real-world\u2019 experience","volume":"21","author":"Ardillon","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0037-1616109","article-title":"von Willebrand Factor Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Recommended abbreviations for von Willebrand Factor and its activities","volume":"86","author":"Mazurier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet-dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bodo","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib18","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2141.1996.d01-1792.x","article-title":"Mutations in a subgroup of patients with mild Haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII: C methods","volume":"94","author":"Rudzki","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-0035-1568877","article-title":"Changing paradigm of hemophilia management: extended half-life factor concentrates and gene therapy","volume":"42","author":"Kumar","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib20","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1055\/s-0034-1543998","article-title":"Treatment of hemophilia in the near future","volume":"41","author":"Peyvandi","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0034-1544004","article-title":"Newer hemostatic agents","volume":"41","author":"Franchini","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1055\/s-0033-1334863","article-title":"Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII: C assays","volume":"39","author":"Duncan","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcp\/111.3.418","article-title":"Binding of von Willebrand factor to collagen by flow cytometry","volume":"111","author":"Kempfer","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1160\/TH12-05-0294","article-title":"A\u00a0novel flow cytometry single tube bead assay for quantitation of von Willebrand factor antigen and collagen-binding","volume":"108","author":"Mina","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2014.05.020","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease in the real world","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1096-8652(200101)66:1<53::AID-AJH1009>3.0.CO;2-I","article-title":"Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor","volume":"66","author":"Favaloro","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","article-title":"Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/ijlh.12087","article-title":"Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease","volume":"35","author":"Verfaillie","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib29","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/hae.12203","article-title":"Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method","volume":"19","author":"Cabrera","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","article-title":"A\u00a0two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen","volume":"20","author":"Stufano","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/hae.12380","article-title":"Diagnosis of inherited von Willebrand disease: comparison of two methodologies and analysis of the discrepancies","volume":"20","author":"Costa-Pinto","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH14-02-0108","article-title":"Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance","volume":"112","author":"de Maistre","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib33","article-title":"Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease","author":"Favaloro","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A\u00a0reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib35","first-page":"77","article-title":"A\u00a0sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ib alpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2016.03.001_bib36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3324\/haematol.11313","article-title":"Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand\u2019s disease by flow cytometry","volume":"92","author":"Giannini","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2016.03.001_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1538-7836.2008.02845.x","article-title":"A\u00a0highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF: RCo) activity assay by flow cytometry","volume":"6","author":"Chen","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib38","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/j.1538-7836.2010.04029.x","article-title":"Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol","volume":"8","author":"Hillarp","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib39","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1111\/j.1538-7836.2010.04123.x","article-title":"Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay","volume":"8","author":"Favaloro","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","article-title":"A\u00a0two centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen","volume":"20","author":"Stufano","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001721-199104000-00011","article-title":"Development of a simple collagen binding assay aids in the diagnosis of, and permits sensitive discrimination between, Type I and Type II von Willebrand's disease","volume":"2","author":"Favaloro","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pathol.2016.03.001_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1613768","article-title":"Collagen binding assay for von Willebrand Factor (VWF: CBA): Detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source","volume":"83","author":"Favaloro","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding (VWF: CB) assay: 21 years of age and beyond adolescence, but not yet a mature adult","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib45","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ijlh.12019","article-title":"Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity","volume":"35","author":"Ni","year":"2013","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib46","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH10-06-0360","article-title":"Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease","volume":"104","author":"Favaloro","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib47","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.03.001_bib48","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/MBC.0b013e328332d022","article-title":"Identification and prevalence of von Willebrand Disease type 2N (Normandy) in Australia","volume":"20","author":"Favaloro","year":"2009","journal-title":"Blood Coag Fibrinolysis"},{"key":"10.1016\/j.pathol.2016.03.001_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.thromres.2010.11.001","article-title":"Interaction of factor VIII and von Willebrand factor and the identification of type 2N von Willebrand disease","volume":"127","author":"Favaloro","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib50","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-2516.2011.02499.x","article-title":"Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis","volume":"17","author":"Veyradier","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-2008-1066019","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib52","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2006-947866","article-title":"Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MBC.0000000000000065","article-title":"Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis","volume":"25","author":"Stockschlaeder","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pathol.2016.03.001_bib54","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-0033-1336833","article-title":"Regulation in hemostasis and thrombosis: part I-in\u00a0vitro diagnostics","volume":"39","author":"Favaloro","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib55","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1538-7836.2012.04729.x","article-title":"Differential sensitivity of von Willebrand factor 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen binding and monoclonal antibody based assays","volume":"10","author":"Favaloro","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib56","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1055\/s-2006-947860","article-title":"Diagnosing von Willebrand disease: a large reference laboratory's perspective","volume":"32","author":"Adcock","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib57","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1373\/clinchem.2012.199000","article-title":"Collagen binding provides a sensitive screen for variant von Willebrand disease","volume":"59","author":"Flood","year":"2013","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2016.03.001_bib58","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MBC.0b013e32834a7e01","article-title":"Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays","volume":"22","author":"Favaloro","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 4","key":"10.1016\/j.pathol.2016.03.001_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/hae.12414","article-title":"von Willebrand disease and platelet disorders","volume":"20","author":"Favaloro","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib61","first-page":"41","article-title":"Perils, problems, and progress in laboratory diagnosis of von Willebrand disease","volume":"40","author":"Flood","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib62","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPH5JK4ONENPAE","article-title":"von Willebrand factor assay proficiency testing: the North American Specialized Coagulation Laboratory Association experience","volume":"135","author":"Chandler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2016.03.001_bib63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib64","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/j.1538-7836.2008.03090.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD) \u2013 a rebuttal","volume":"6","author":"Favaloro","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1532\/LH96.04063","article-title":"Laboratory diagnosis of von Willebrand Disorder: Use of multiple functional assays reduces diagnostic error rates","volume":"11","author":"Favaloro","year":"2005","journal-title":"Lab Hematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1055\/s-2006-947865","article-title":"Reducing errors in identification of von Willebrand disease: The experience of the Royal College of Pathologists of Australasia Quality Assurance Program","volume":"32","author":"Favaloro","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib67","doi-asserted-by":"crossref","DOI":"10.1111\/hae.12903","article-title":"Type 2M von Willebrand disease \u2013 more often misidentified than correctly identified","author":"Favaloro","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1309\/LM749BQETKYPYPVM","article-title":"Preanalytical variables in coagulation testing associated to diagnostic errors in hemostasis","volume":"43","author":"Favaloro","year":"2012","journal-title":"Lab Med"},{"key":"10.1016\/j.pathol.2016.03.001_bib69","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/107602969700300208","article-title":"Laboratory assessment of von Willebrand factor: altered interpretation of laboratory data, and altered diagnosis of von Willebrand's disease, as influenced by the use of different vWF assays and assay conditions","volume":"3","author":"Favaloro","year":"1997","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0032-1315961","article-title":"Quality standards for sample collection in coagulation testing","volume":"38","author":"Lippi","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib71","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0032-1319768","article-title":"Quality standards for sample processing, transportation, and storage in hemostasis testing","volume":"38","author":"Adcock Funk","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib72","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.thromres.2008.10.008","article-title":"Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF: CB and VWF: RCo) von Willebrand factor activity assays?","volume":"123","author":"Favaloro","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib73","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MBC.0b013e32832da1ad","article-title":"Potential supplementary utility of combined PFA-100 and functional VWF testing for the laboratory assessment of desmopressin and factor concentrate therapy in von Willebrand disease","volume":"20","author":"Favaloro","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pathol.2016.03.001_bib74","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2016.03.001_bib75","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12064","article-title":"A\u00a0comparative evaluation of a new automated assay for von Willebrand factor activity","volume":"19","author":"Lawrie","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib76","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","article-title":"Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin","volume":"36","author":"Graf","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib77","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.thromres.2014.04.033","article-title":"Comparison of Von Willebrand factor (VWF) activity VWF: Ac with VWF ristocetin cofactor activity VWF: RCo","volume":"134","author":"Geisen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib78","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/MBC.0000000000000169","article-title":"Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin","volume":"25","author":"Patzke","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pathol.2016.03.001_bib79","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2141.1985.tb07350.x","article-title":"An immunoradiometric assay for human factor VIII\/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope","volume":"59","author":"Goodall","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0038-1661555","article-title":"A\u00a0two-site, monoclonal antibody-based immunoassay for von Willebrand factor\u2013demonstration that vWF function resides in a conformational epitope","volume":"55","author":"Chand","year":"1986","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0049-3848(87)90261-1","article-title":"A\u00a0monoclonal antibody based immunoradiometric assay for von Willebrand factor: survey of a large patient group","volume":"45","author":"McCraw","year":"1987","journal-title":"Thromb Res"},{"key":"10.1016\/j.pathol.2016.03.001_bib82","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib83","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1309\/2PMF-3HK9-V8TT-VFUN","article-title":"Detection of von Willebrand Disorder (VWD) and identification of qualitative von Willebrand Factor (VWF) defects: Direct comparison of commercial ELISA-based \u2018VWF: Activity\u2019 options","volume":"114","author":"Favaloro","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2016.03.001_bib84","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1055\/s-0037-1614064","article-title":"Discrimination of von Willebrands disease (VWD) subtypes: direct comparison of von Willebrand factor:collagen binding activity\/assay (VWF: CBA) with monoclonal antibody (MAB) based ELISA VWF-detection systems","volume":"84","author":"Favaloro","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib85","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/1076029606291428","article-title":"Determination of von Willebrand factor activity: evaluation of the HaemosIL assay in comparison with established procedures","volume":"12","author":"Sucker","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib86","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1309\/CEPND3LFHQ87XU4D","article-title":"A\u00a0new automated screening assay for the diagnosis of von Willebrand disease","volume":"127","author":"Salem","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2016.03.001_bib87","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.10766","article-title":"Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease","volume":"92","author":"Pinol","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2016.03.001_bib88","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2011.04460.x","article-title":"Validation of an automated latex particle-enhanced immunoturbidimetric von Willebrand factor activity assay","volume":"9","author":"Chen","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1538-7836.2009.03482.x","article-title":"Genetic testing for von Willebrand disease: the case against","volume":"8","author":"Favaloro","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib90","first-page":"37","article-title":"Genetic testing for the diagnosis of von Willebrand disease: benefits and limitations","volume":"2","author":"Favaloro","year":"2010","journal-title":"J\u00a0Coagul Dis"},{"key":"10.1016\/j.pathol.2016.03.001_bib91","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/ijlh.12161","article-title":"The automation of routine light transmission platelet aggregation","volume":"36","author":"Lawrie","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pathol.2016.03.001_bib92","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1538-7836.2010.03857.x","article-title":"Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome","volume":"8","author":"De Moerloose","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MBC.0b013e32836466b5","article-title":"Clinical performance of anticardiolipin and anti\u03b22 glycoprotein I antibodies using a new automated chemiluminescent assay: superior thrombotic prediction of combined results measured by two different methods","volume":"25","author":"Chung","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.pathol.2016.03.001_bib94","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1515\/cclm-2014-0925","article-title":"The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-\u03b22 glycoprotein I antibodies. A comparison with a homemade ELISA method","volume":"53","author":"Meneghel","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2016.03.001_bib95","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/hae.12243","article-title":"Erik von Willebrand","volume":"19","author":"Lassila","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.pathol.2016.03.001_bib96","article-title":"Bleeding assessment tools: limits and advantages for the diagnosis and prognosis of inherited bleeding disorders","volume":"42","author":"Tosetto","year":"2016","journal-title":"Semin Thromb Haemost"},{"key":"10.1016\/j.pathol.2016.03.001_bib97","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.10816","article-title":"High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls","volume":"92","author":"Quiroga","year":"2007","journal-title":"Haematologica"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516377212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516377212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T11:17:19Z","timestamp":1600514239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516377212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0031302516377212"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.03.001","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laboratory tests used to help diagnose von Willebrand disease: an update","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}